{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:15:08Z","timestamp":1759565708624,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The authors present here a case of a pharmacobezoar after drug overdose, diagnosed using multiple blood samples for TDM. This grand round highlights the importance of a dialog between a clinician and a TDM consultant for the optimal care of a patient.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000860","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T21:09:01Z","timestamp":1608325741000},"page":"143-145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacobezoar After Venlafaxine and Oxazepam Overdose: How Pharmacokinetics Could Help?\u2014A Grand Round"],"prefix":"10.1097","volume":"43","author":[{"given":"Rapha\u00ebl","family":"Laurent","sequence":"first","affiliation":[{"name":"Service De R\u00e9animation, Clinique De La Mutualiste Chirurgicale, Saint Etienne; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Varvat","sequence":"additional","affiliation":[{"name":"Service De R\u00e9animation, Clinique De La Mutualiste Chirurgicale, Saint Etienne; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Goudard","sequence":"additional","affiliation":[{"name":"Service De R\u00e9animation, Clinique De La Mutualiste Chirurgicale, Saint Etienne; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[{"name":"Laboratoire De Pharmacologie, Toxicologie, Gaz Du Sang, Plateau De Biologie, Chu De Saint Etienne-Saint Etienne, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Gauthier","sequence":"additional","affiliation":[{"name":"Service De R\u00e9animation, Clinique De La Mutualiste Chirurgicale, Saint Etienne; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Launay","sequence":"additional","affiliation":[{"name":"Laboratoire De Pharmacologie, Toxicologie, Gaz Du Sang, Plateau De Biologie, Chu De Saint Etienne-Saint Etienne, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharma.2017.01.002","article-title":"Toxicodynetics in nordiazepam and oxazepam overdoses","volume":"75","author":"Sacre","year":"2017","journal-title":"Ann Pharm Fr."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit Care Lond Engl."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/1060028014550645","article-title":"Risk of QT\/QTc prolongation among newer non-SSRI antidepressants","volume":"48","author":"Jasiak","year":"2014","journal-title":"Ann Pharmacother."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF03160945","article-title":"A fatal case of venlafaxine overdose","volume":"4","author":"Bosse","year":"2008","journal-title":"J Med Toxicol."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1258\/rsmmsl.49.4.257","article-title":"Concentration distributions of the drugs most frequently identified in post-mortem femoral blood representing all causes of death","volume":"49","author":"Jones","year":"2009","journal-title":"Med Sci L."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"rjy116","DOI":"10.1093\/jscr\/rjy116","article-title":"Pharmacobezoar-a rare case presented as gastric outlet obstruction","volume":"2018","author":"Jain","year":"2018","journal-title":"J Surg Case Rep."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4253\/wjge.v7.i4.336","article-title":"Review of the diagnosis and management of gastrointestinal bezoars","volume":"7","author":"Iwamuro","year":"2015","journal-title":"World J Gastrointest Endosc."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199512010-00006","article-title":"Controlled release drugs in overdose. Clinical considerations","volume":"12","author":"Buckley","year":"1995","journal-title":"Drug Saf."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.1097\/MJT.0000000000000114","article-title":"Type B lactic acidosis associated with venlafaxine overdose","volume":"23","author":"Iragavarapu","year":"2016","journal-title":"Am J Ther."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcp.12793","article-title":"Activated charcoal for acute overdose: a reappraisal","volume":"81","author":"Juurlink","year":"2016","journal-title":"Br J Clin Pharmacol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:28:15Z","timestamp":1748971695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000860","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"2020-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}